Literature DB >> 15738712

Precipitation of insulin products used for continuous subcutaneous insulin infusion.

Christian Poulsen1, Lotte Langkjaer, Carsten Worsøe.   

Abstract

BACKGROUND: Commercially available insulin products used for continuous subcutaneous insulin infusion have been compared with respect to resistance towards isoelectric insulin precipitation.
METHODS: The degree of isoelectric insulin precipitation of insulin aspart injection (IAsp), insulin lispro injection (ILis), and buffered human regular insulin injection (BHR) was examined while reducing pH through addition of diluted HCl or exposure to CO2.
RESULTS: The pH at which defined fractions of the insulins precipitated differed among the three products; 10% and 90% precipitation, respectively, was observed at pH 6.41 and pH 6.30 for ILis, pH 6.18 and pH 5.95 for BHR, and pH 5.90 and pH 5.67 for IAsp, in accordance with the isoelectric points of these insulin species. The amount of H(+)-equivalents per microliter of product to reach 10% precipitation was found to be highest for IAsp (5.49 nmol of H(+)-equivalents), with ILis and BHR almost equivalent to each other (4.46 and 4.32 nmol of H(+)-equivalents, respectively). Exposure to a CO2-enriched environment resulted in the same order of insulin precipitation of the three products as tested with HCl.
CONCLUSIONS: Resistance towards isoelectric precipitation is highest for IAsp, lowest for ILis, and intermediate for BHR. Isoelectric precipitation will alter the pharmacokinetic properties of the insulin and could lead to occlusion of the infusion catheter, causing elevated blood glucose and ultimately causing diabetic ketoacidosis if no intervention is made. Causal relationships between the observed differences in resistance towards isoelectric precipitation of the insulin products, the mechanism behind catheter occlusion, and the clinical relevance of the observations require further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15738712     DOI: 10.1089/dia.2005.7.142

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  11 in total

Review 1.  Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.

Authors:  Anneke Graf; Sybil A McAuley; Catriona Sims; Johanna Ulloa; Alicia J Jenkins; Gayane Voskanyan; David N O'Neal
Journal:  J Diabetes Sci Technol       Date:  2016-12-13

Review 2.  Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review.

Authors:  David Kerr; Erik Wizemann; Jakob Senstius; Mette Zacho; Francisco Javier Ampudia-Blasco
Journal:  J Diabetes Sci Technol       Date:  2013-11-01

3.  Quantitation of humalog insulin by reversed-phase high-performance liquid chromatography.

Authors:  Carey Munsick; Robert Murray; Tom Dziubla; Anthony M Lowman; Jeffrey I Joseph; Marc C Torjman
Journal:  J Diabetes Sci Technol       Date:  2007-07

4.  Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.

Authors:  Volkmar Schmid; Cloth Hohberg; Marcus Borchert; Thomas Forst; Andreas Pfützner
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

5.  Compatibility of insulin Lispro, Aspart, and Glulisine with the Solo MicroPump, a novel miniature insulin pump.

Authors:  Gil Senesh; Doron Bushi; Avraham Neta; Ofer Yodfat
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

Review 6.  Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.

Authors:  Reinhard H A Becker; Annke D Frick
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 7.  Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion.

Authors:  Lutz Heinemann; Lars Krinelke
Journal:  J Diabetes Sci Technol       Date:  2012-07-01

8.  Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.

Authors:  Andreas Pfützner; Daniela Sachsenheimer; Marco Grenningloh; Matthias Heschel; Lene Walther-Johannesen; Rabi Gharabli; David Klonoff
Journal:  J Diabetes Sci Technol       Date:  2015-09-03

9.  The role of insulin glulisine to improve glycemic control in children with diabetes mellitus.

Authors:  Anna Lih; Emily Hibbert; Tang Wong; Christian M Girgis; Nidhi Garg; John N Carter
Journal:  Diabetes Metab Syndr Obes       Date:  2010-11-26       Impact factor: 3.168

Review 10.  Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience.

Authors:  Kjeld Hermansen; Mette Bohl; Anne Grethe Schioldan
Journal:  Drugs       Date:  2016-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.